Protocol Ledger

NCT06958328 · Phase III · RECRUITING

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Interventional Phase III clinical trial protocol NCT06958328 sponsored by NRG Oncology in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-08-21 Enrollment: 356 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06958328
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)356 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06958328
Protocol FieldVerified Registry Value
NCT IdentifierNCT06958328
Consolidated Lead SponsorNRG Oncology
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment356 participants (ESTIMATED)
Registered Start Date2025-08-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06958328
Hospital Research SiteLocationSite Profile
Banner MD Anderson Cancer CenterGilbert, AZOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI